Back to top

Enliven price target raised to $80 from $60 at Stifel

Stifel raised the firm’s price target on Enliven (ELVN) to $80 from $60 and keeps a Buy rating on the shares. The firm is “more bullish” on its sec...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Enliven Therapeutics, Inc. (ELVN)